Cargando…

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC

Radiomics has become an area of interest for tumor characterization in (18)F-Fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) imaging. The aim of the present study was to demonstrate how imaging phenotypes was connected to somatic mutations through an integrated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaofeng, Yin, Guotao, Zhang, Yufan, Dai, Dong, Liu, Jianjing, Chen, Peihe, Zhu, Lei, Ma, Wenjuan, Xu, Wengui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803612/ https://www.ncbi.nlm.nih.gov/pubmed/31681597 http://dx.doi.org/10.3389/fonc.2019.01062

Ejemplares similares

Predictive Value of (18)F-FDG PET/CT-Based Radiomics Model for Occult Axillary Lymph Node Metastasis in Clinically Node-Negative Breast Cancer
por: Chen, Kun, et al.
Publicado: (2022)

Enhanced glucose metabolism mediated by CD147 is associated with (18)F‐FDG PET/CT imaging in lung adenocarcinoma
por: Zhang, Yufan, et al.
Publicado: (2020)

Prediction of EGFR Mutation Status Based on (18)F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
por: Yin, Guotao, et al.
Publicado: (2021)

Corrigendum: Prediction of EGFR Mutation Status Based on (18)F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
por: Yin, Guotao, et al.
Publicado: (2021)

(18)F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model
por: Li, Xiaofeng, et al.
Publicado: (2020)

(18)F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma
por: Xu, Jie, et al.
Publicado: (2019)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Correlation between EGFR mutation status and F(18)‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2019)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

Performance of (18)F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
por: Zhang, Min, et al.
Publicado: (2020)

Hematogenous muscular metastasis of NSCLC in FDG-PET/CT
por: Satoh, Hiroaki, et al.
Publicado: (2015)

Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
por: Qian, Luo-Dan, et al.
Publicado: (2023)

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [(18)F]FDG PET/CT: A Comparison between Two PET/CT Scanners
por: Dondi, Francesco, et al.
Publicado: (2022)

Impact of (18)F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
por: Al-Ibraheem, Akram, et al.
Publicado: (2021)

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features
por: Huang, Weicheng, et al.
Publicado: (2022)

Primary tumor standardized uptake value (SUVmax) measured on (18)F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer
por: Hui, Zhenzhen, et al.
Publicado: (2020)

The predictive value of [(18)F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

Optimal (18)F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study
por: Zuo, Yan, et al.
Publicado: (2023)

Radiomic analysis for predicting prognosis of colorectal cancer from preoperative (18)F-FDG PET/CT
por: Lv, Lilang, et al.
Publicado: (2022)

Frontiers and hotspots of (18)F-FDG PET/CT radiomics: A bibliometric analysis of the published literature
por: Liu, Xinghai, et al.
Publicado: (2022)

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020)

The predictive value of (18)F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population
por: Wang, Jian, et al.
Publicado: (2022)

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
por: Digumarthy, Subba R., et al.
Publicado: (2019)

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
por: van Timmeren, Janna E., et al.
Publicado: (2019)

Value of (18)F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
por: Yang, Bin, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Advanced NSCLC: [(18)F]FDG PET/CT as a Troubleshooter in Treatment Response
por: Ferrari, Cristina, et al.
Publicado: (2021)

Prediction of 2-[(18)F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
por: Stanzione, Arnaldo, et al.
Publicado: (2023)

Preoperative (18)F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma
por: Choi, Wookjin, et al.
Publicado: (2023)

Ability of (18)F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
por: Ou, Xuejin, et al.
Publicado: (2019)

Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on (18)F-FDG PET/CT radiomics
por: Xing, Haiqun, et al.
Publicado: (2021)

Breast Tumor Characterization Using [(18)F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics
por: Krajnc, Denis, et al.
Publicado: (2021)

A review on advances in (18)F-FDG PET/CT radiomics standardisation and application in lung disease management
por: Anan, Noushin, et al.
Publicado: (2022)

Radiomics analysis improves (18)FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2021)

Exploratory analysis of radiomic as prognostic biomarkers in (18)F-FDG PET/CT scan in uterine cervical cancer
por: de Alencar, Nadja Rolim Gonçalves, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer
por: Burchardt, Ewa, et al.
Publicado: (2023)

(18)F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study
por: Xu, Xiaojun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ug82ompbnc9lieki29f08ul5m